
· Executive Brief
Gastroparesis Awareness Month 2026
A practical executive framework for access, ownership, handoffs, measurement, and improvement.

Leadership signal
Gastroparesis Awareness Month can serve as an executive operating checkpoint.
Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Gastroparesis is a coordination problem that surfaces in acute care
Gastroparesis is a chronic disorder of delayed gastric emptying without mechanical obstruction. It is uncommon in claims data but costly in daily operations. A 2026 review reported that the prevalence of definite gastroparesis was 21.5 per 100 000 persons in a 2018 U.S. claims study.[1] The same review describes a condition that is more common among females, with a ratio of 2:1–4:1.[1]
The executive concern is less the size of the population than the way its care is organized. Many patients are seen first in primary care, emergency departments or endocrine clinics, while confirmatory testing and specialist decisions sit in motility services that are scarce. In a study of 406 patients with gastroparesis symptoms, 39% had prior emergency department visits and 23% had been hospitalized for their symptoms in the past year.[13] Community patterns may differ, but the direction is a useful warning for any system.
Those encounters are signals of a pathway that is not holding between visits. Diagnosis depends on a standardized test that not every site can offer. Nutrition support depends on dietitians who are often absent from the referral route. Medication review depends on someone noticing drugs that slow gastric emptying. Each step belongs to a different team, and the handoffs between them are rarely measured. When those handoffs fail, the patient’s next contact is often unplanned, and the plan has to be rebuilt in a crowded emergency department.
Gastroparesis Awareness Month is a practical moment to ask where those steps fail. The sections below summarize peer-reviewed evidence on burden, diagnostic standards, access to testing, nutrition, acute care use, equity, patient experience and cost. They are written to sit beside the executive guidance already on this page. They give operating leaders and boards a shared factual base, not individual clinical advice.
Current evidence
What the research says about burden, causes and measurement
The origins of gastroparesis point directly to services health systems already run. In a U.S. epidemiological study involving 82.6 million patients, type 2 diabetes accounted for 51.7% of gastroparesis, postsurgical effects for 15%, medication-induced disease for 11.8% and idiopathic disease for 11.3%.[1] Diabetes programs, surgical services and pharmacy teams therefore all touch the population before a motility clinic does. The condition is also more common among females, which matters for the women’s health and diabetes services that often see these patients first.[1]
Underrecognition is common within those services. In a 2026 cross-sectional study of 130 randomly selected outpatients with type 2 diabetes, delayed gastric emptying was found in 13.1% of participants on scintigraphy.[6] Higher HbA1c (odds ratio 6.99), higher BMI (odds ratio 3.89) and longer diabetes duration (odds ratio 2.75) were independent predictors.[6] Symptom scores showed limited agreement with measured emptying, so symptom screening alone is not a reliable route to diagnosis.[6]
Medication exposure adds a newer source of risk. A 2026 systematic review of glucagon-like peptide-1 receptor agonist cases identified twelve case reports describing 13 patients with symptomatic gastroparesis.[3] Onset ranged from hours to several months after starting therapy and often followed dose escalation or inappropriate re-initiation, and symptoms resolved in all reported patients after the drug was stopped.[3] The evidence base is small, but the operating implication is clear: prescribing growth needs a matching route for recognizing gastrointestinal intolerance.
Population measurement remains weak. A systematic review of 13 epidemiologic studies found that prevalence of definite gastroparesis ranged from 13.8 to 267.7 per 100,000 adults.[15] In most studies (76.9%), cases were identified solely through diagnosis codes or clinical records, and only 2 studies (15.4%) used objective evaluation.[15] Local registries built on billing codes alone will therefore misstate both the size and the mix of the population. Only 4 studies (30.8%) used non-specialized community databases, while the remainder drew on inpatient, emergency department or disease-specific sources.[15] Incidence ranged from 1.9–6.3 per 100,000 person-years.[15]
The same review found that hospitalizations and emergency visits for gastroparesis had increased from 2- to 18-fold over approximately 2 decades.[15] Read together, these studies describe a condition that is easy to miss, hard to count and expensive to leave unmanaged. That combination calls for pathway ownership rather than a single specialty solution.
Figure 1
Acute care is a frequent part of gastroparesis care
Percent of patients with the reported event or outcome, as reported in each study. Values are copied from the cited studies [2], [9], [13]; none is estimated.
Data note. These values come from different studies, populations, time windows and definitions, so this is an indirect comparison; the bars show how often acute care and limited improvement appear, not how one setting compares with another.
Limitation. Prior-year values are questionnaire-reported in one cohort; five-year values come from a retrospective record cohort; improvement uses a one-point symptom index threshold.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Prior-year emergency department visit | 39% | 159 of 406 patients with gastroparesis symptoms in one cohort study | [13] |
| Prior-year hospitalization for gastroparesis symptoms | 23% | 92 of 406 patients with gastroparesis symptoms in the same study | [13] |
| Emergency visit within five years, nonoperative cohort | 54.7% | 1243 of 2272 matched nonoperative adults with diabetic gastroparesis, U.S. national multicenter cohort, 2010 to 2023 | [2] |
| Hospitalization within five years, nonoperative cohort | 59% | 1340 of 2272 matched nonoperative adults with diabetic gastroparesis in the same cohort | [2] |
| Symptom score improved by at least one point at 48 weeks | 26% | 555 patients in a multicenter registry followed over 48 weeks | [9] |

Continuum of care
Where the continuum breaks between testing, treatment and recovery
The continuum begins with a standardized test. Current U.S. guidelines described in the 2026 review define gastric emptying scintigraphy with more than 10% gastric retention at 4 hours as the criterion standard.[1] Severity is then graded by retention at 4 hours as mild (10%-15%), moderate (16%-35%) or severe (>35%).[1] Sites that run shorter protocols or report results differently create downstream confusion for every clinician who reads them. The review also notes that a carbon 13 spirulina breath test is approved by the U.S. Food and Drug Administration for diagnosis.[1]
Treatment then moves in steps that cross several teams. The review lists stopping medications that delay emptying, such as opioids, cannabis, anticholinergics and glucagon-like peptide-1 receptor agonists, and improving glycemic control in diabetes.[1] First-line therapy combines a small particle diet with antiemetics, and severe cases may need liquid diets, jejunal feeding or procedures.[1] Pharmacy, endocrinology, nutrition and endoscopy each own a part of that sequence.
Response to care is uneven and needs follow-up to detect. In a multicenter registry of 1013 patients, the most common predominant symptoms were nausea (31%), vomiting (20%) and abdominal pain (20%).[9] Among 555 patients followed over 48 weeks, symptom scores improved by at least one point in 26% overall.[9] Improvement was more frequent when the initial predominant symptom was nausea (32%) or bloating (35%) and less frequent for fullness (13%) or abdominal pain (15%).[9]
For patients with refractory disease, the continuum extends into procedural care. In a national multicenter cohort of 95,328 adults with diabetes and gastroparesis, 2,272 (2.4%) underwent surgical therapy.[2] Over five years, emergency visits occurred in 41.7% of the surgical cohort versus 54.7% of matched nonoperative patients, and hospitalizations in 45.5% versus 59.0%.[2] These are associations in a retrospective cohort, but they show how much acute care accumulates when refractory disease is not resolved. Diabetes-related complications at five years occurred in 53.2% of the surgical cohort and 63.3% of the nonoperative cohort.[2]
Executives can read these findings as a map of handoffs. Testing, medication review, nutrition, symptom tracking and procedural referral each need a named owner and a defined return path to primary care. Without that, the emergency department becomes the default point of contact between scheduled visits. Each return path should specify which results, medication changes and nutrition goals travel with the patient, and who confirms that they arrived.
Figure 3
Why the pathway breaks
People
- Few motility specialists to interpret tests and set plans
- Limited dietitian access with motility experience
- Little behavioral health support for fatigue and distress
Process
- No routine medication review for drugs that slow gastric emptying
- No defined return path from motility services to primary care
- Emergency visits not linked to an outpatient plan
Technology
- Gastric emptying studies not run to the four-hour standard at every site
- Alternative tests not standardized
- Care plans not visible across emergency and outpatient records
Environment
- Distance to nuclear medicine departments
- Rural residence and loneliness
- Low income limiting access to diet and follow-up
Policy
- Dietary guidance built mainly on diabetic disease
- Procedure value judged on short time horizons
- Rapid growth of medications associated with delayed emptying
Measurement
- Registries built on diagnosis codes alone
- Symptom scores used in place of objective testing
- Utilization not stratified by race, income or rurality
Unranked qualitative cause-and-effect diagram for the outcome in the box: Patients with gastroparesis cycle through emergency care without a timely diagnosis, nutrition plan or stable outpatient owner Causes are assembled from the cited literature [1], [3], [4], [5], [6], [7], [10], [11], [13], [14], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Few motility specialists to interpret tests and set plans; Limited dietitian access with motility experience; Little behavioral health support for fatigue and distress |
| Process | No routine medication review for drugs that slow gastric emptying; No defined return path from motility services to primary care; Emergency visits not linked to an outpatient plan |
| Technology | Gastric emptying studies not run to the four-hour standard at every site; Alternative tests not standardized; Care plans not visible across emergency and outpatient records |
| Environment | Distance to nuclear medicine departments; Rural residence and loneliness; Low income limiting access to diet and follow-up |
| Policy | Dietary guidance built mainly on diabetic disease; Procedure value judged on short time horizons; Rapid growth of medications associated with delayed emptying |
| Measurement | Registries built on diagnosis codes alone; Symptom scores used in place of objective testing; Utilization not stratified by race, income or rurality |
Access
Making testing, nutrition and specialist judgment reachable
Access starts with testing capacity. Gastric emptying scintigraphy depends on nuclear medicine departments, and a 2026 review of 13 pediatric papers noted that some children cannot tolerate the study or reach such a department.[11] Alternatives such as breath tests and wireless motility capsules exist but are limited by a lack of standardization and availability.[11] The review concluded that scintigraphy remains the standard test for children until other tests are standardized.[11]
Faster bedside options are being studied. In a 2026 prospective diagnostic accuracy study, 113 participants completed both a 15-minute gastric ultrasound protocol and scintigraphy.[7] In the validation cohort, the ultrasound threshold showed a sensitivity of 93.2% and a specificity of 88.3% against 4-hour scintigraphy.[7] The authors positioned ultrasound as a screening step to identify patients who should proceed to scintigraphy, not as a replacement.[7] The validation threshold yielded an area under the curve of 0.90, and reproducibility was excellent.[7] For systems with long nuclear medicine waits, that framing is a triage question worth testing locally.
Specialist interpretation also shapes access. In a 2026 randomized pilot at a tertiary center, a diagnosis was established in 2 of 16 patients (12.5%) at baseline and in 8 of 16 (50.0%) when two tests were combined.[10] Motility specialists changed management in 75.0% and 62.5% of patients after reviewing the second test result.[10] The study is small, but it shows that test results become useful only when an experienced reviewer can act on them.
Nutrition support is the least visible access gap. A 2026 scoping review screened 6212 articles and found only 13 studies of dietary management in nondiabetic gastroparesis.[4] Only 5 reported nutritional outcomes, and no study examined the role of diet in disordered eating.[4] The authors noted that patients with nondiabetic gastroparesis experience higher malnutrition and mortality rates, yet guidance is built mainly on diabetic disease.[4] That evidence gap places more weight on dietitian judgment and on clear referral routes to dietitians with motility experience.
Taken together, these studies suggest that access depends on linked capacities: a standardized test, an experienced interpreter and a nutrition service. When one is missing, the others lose much of their value. Executives can review all three as one access problem rather than three separate departmental queues.
Executive guidance · System route
Build one visible operating route for Gastroparesis Awareness Month.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Clarify the navigation route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Clarify the navigation route
Connect plain-language information, locally appropriate entry points, receiving services, transition ownership, and follow-through without implying one clinical pathway.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Clarify the navigation route | Connect plain-language information, locally appropriate entry points, receiving services, transition ownership, and follow-through without implying one clinical pathway. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Who carries the heaviest burden of acute care
Acute care use in gastroparesis is not evenly distributed. In the study of 406 patients, factors independently associated with emergency visits in the prior year included younger age, Black race and lower income.[13] The same factors, along with diabetic etiology and depression scores, were associated with more hospitalizations.[13] These are associations, not explanations, but they identify where outpatient access and continuity are most likely to be failing. The most frequent reasons for hospitalization were nausea (83%), vomiting (78%), abdominal pain (70%) and dehydration (59%).[13] Those are the symptoms that outpatient plans are meant to manage, which makes them a practical focus for review.
Social conditions shape outcomes outside the clinic. A retrospective analysis of 50 patients with diabetic gastroparesis, drawn from a cohort of 250 patients with gastroparesis, found that low income was associated with more complications, frequent hospitalizations and higher healthcare expenditure.[14] Loneliness emerged as a significant aggravating factor, and most patients lived in rural areas.[14] The study is small, so it supports screening for social needs rather than precise local targets.
Substance use and stigma add another layer. A propensity-matched analysis of 41,374 adults with gastroparesis found that cannabis use was associated with more emergency visits (adjusted odds ratio 1.73) and more hospitalizations (adjusted odds ratio 1.44).[12] The authors called for prospective studies before drawing firm conclusions.[12] For operations, the finding argues for nonjudgmental medication and substance review in every acute encounter, so that patients are not lost between emergency care and outpatient follow-up. Cannabis users in that analysis were younger, with higher rates of diabetes, mood or anxiety disorders and opioid use.[12]
Trust depends on whether patients find a stable outpatient home. When the same groups repeatedly appear in emergency departments, the gap may be access to testing, nutrition and follow-up rather than motivation. Executives can test equity directly by stratifying emergency use, admissions and time to testing by race, income and rurality, and by asking patients what made outpatient care hard to reach.
Published data offer limited help with that task. The epidemiology review found that all but one included study came from the United States and called for more demographically diverse, population-based research.[15] Local equity analysis therefore has to be built from the organization’s own stratified data rather than borrowed rates.

Human infrastructure
The people who hold a gastroparesis pathway together
Gastroparesis care relies on a small group of specialized people. Motility gastroenterologists, nuclear medicine technologists, dietitians, endocrinology teams, pharmacists, emergency clinicians and primary care teams each own part of the route. When any role is thin, patients wait for testing, cycle through acute care or receive advice that does not match their condition. Each of these roles also carries competing demands, so gastroparesis work is easily crowded out unless it is scheduled, staffed and reviewed like any other service line.
Specialist time is the scarcest resource. In the randomized pilot, management decisions changed for most patients once motility specialists reviewed a second test result.[10] That kind of judgment cannot be scaled by adding referrals alone. It needs protected clinic time, clear criteria for who is referred and a defined plan to send stable patients back to primary care. In the same pilot, symptom profiling phenotyped 5 additional patients whose test results were normal, a reminder that interpretation goes beyond a single number.[10]
Dietitians carry a large share of the work with little evidence to lean on. The scoping review found considerable variation in dietary management strategies across studies and a lack of standardization in intervention protocols.[4] Systems that want consistent nutrition care will need to invest in dietitian training, shared protocols and routine measurement of nutritional status, because the literature does not yet supply them.[4] Only two of the included studies were randomized trials, and together they enrolled 16 participants with nondiabetic gastroparesis.[4]
Test capacity is also a workforce question. The pediatric review recommended multicenter collaboration to strengthen consensus recommendations for gastric emptying studies.[11] Protocol adherence depends on technologists who are trained to run and report four-hour studies the same way across sites. Leaders can treat protocol consistency as a quality indicator with an accountable owner rather than a departmental detail.
Behavioral health belongs in the staffing plan. In a cross-sectional study of 114 people with gastroparesis, 97.3% reported experiencing brain fog, and symptom severity was positively related to fatigue and psychological distress.[8] The authors recommended screening for these variables as part of gastroparesis management.[8] Fatigue partially mediated the relationship between symptoms and quality of life.[8] Pathways that include psychology or social work support are better placed to respond to that burden, and emergency clinicians benefit from knowing those supports exist.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Navigation reliability
Do people and teams know where questions and locally approved referrals go next?
- Candidate local measure
- Locally defined misroutes, repeated contacts, incomplete information, unaccepted handoffs, and navigation feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Navigation reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the receiving service, required information, current status, and next contact under the locally approved route.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Navigation reliability | Do people and teams know where questions and locally approved referrals go next? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable gastroparesis pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Four-hour gastric emptying protocol used and reported consistently | Results are not comparable across sites and severity is misclassified | Nuclear medicine director with motility lead | Share of studies meeting the protocol at each site |
| Medication review for drugs that slow gastric emptying | Reversible causes persist and symptoms recur | Pharmacy and therapeutics lead | Share of new referrals with a documented medication review |
| Defined referral criteria and wait standard for motility services | Specialists are overloaded and urgent patients wait | Gastroenterology service line leader | Days from referral to completed test and specialist plan |
| Dietitian referral for every confirmed patient | Malnutrition goes unrecognized and diet advice varies | Clinical nutrition manager | Share of confirmed patients seen by a dietitian and nutritional status recorded |
| Shared care plan visible in emergency and outpatient settings | Repeat emergency visits restart care rather than continue it | Emergency medicine and primary care medical directors | Share of repeat emergency visits with an accessible plan |
| Stratified utilization review | Disparities in emergency use and admissions stay hidden | Chief quality officer and board quality committee | Emergency visits, admissions and time to testing by race, income and rurality |
Control points derived from the cited evidence [1], [3], [4], [10], [13], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating about gastroparesis with accuracy and restraint
Public messages about gastroparesis should help people find a reliable next step, not suggest a diagnosis. Because symptoms show limited agreement with measured gastric emptying, communications that encourage self-labeling can add confusion.[6] A clearer message invites people with persistent symptoms to raise them with their clinician and explains how testing works in the organization. Once wait times are defined and measured locally, publishing where testing is done and how long it usually takes can reduce repeat calls and uncertainty.
Patient experience data can inform tone. In the cross-sectional study, participants had a mean age of 40.63 years and 87.7% were female.[8] Gastroparesis symptom severity had a significant negative relationship with quality of life.[8] Messages written for this population should acknowledge fatigue and distress, offer practical routes to support and avoid implying that symptoms reflect a lack of effort.
Medication communication deserves particular care. With wider use of glucagon-like peptide-1 receptor agonists, patients and prescribers need clear information about gastrointestinal symptoms that warrant review.[3] The review authors recommended careful patient selection, gradual dose titration and monitoring for persistent symptoms.[3] Organizations can reflect that guidance in prescriber education and patient materials without creating alarm about widely used therapies.
Cost and value conversations also need accurate framing. A 2026 cost-effectiveness analysis found that botulinum toxin injection was cost-effective at 3 months, while gastric peroral endoscopic myotomy became the cost-effective option at 12 months.[5] At 3 months, the endoscopic procedure carried an incremental cost-effectiveness ratio of $288,341/QALY against a willingness-to-pay threshold of $100,000/QALY.[5] Results depended mainly on clinical success rates and procedural costs, so public statements about value should describe trade-offs rather than promise savings.[5] Once repeat injections were counted at 12 months, botulinum toxin injection yielded a ratio of $334,046/QALY relative to the endoscopic procedure.[5]
Internal communication matters as much as public messaging. Emergency clinicians, primary care teams and motility services need a shared summary of each patient’s plan, test results and nutrition goals. When that summary travels with the patient, repeat visits become a chance to reinforce the plan rather than restart it. The registry authors concluded that a patient’s predominant symptom provides useful information about their present condition and future outcome.[9] That makes it a practical item to record in every shared plan.

Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how Gastroparesis Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Map one high-friction navigation route and correct a verified entry, information, or ownership barrier.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how Gastroparesis Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Map one high-friction navigation route and correct a verified entry, information, or ownership barrier. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make Gastroparesis Awareness Month a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Month observance
Turn Gastroparesis Awareness Month into accountable action.
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership focus
Use this observance to examine navigation, longitudinal ownership, and specialty-care coordination. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, nutrition support, specialty navigation, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, food access, transportation, coverage, digital access, geography, and the burden of navigating multiple services.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, caregivers, primary care, specialty services, nutrition teams, and community partners. Find one confusing information, an unowned referral, or a support need that remains unresolved, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Clarify the navigation route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined misroutes, repeated contacts, incomplete information, unaccepted handoffs, and navigation feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Patient Experience and Access Leaders
Staff communication template
During Gastroparesis Awareness Month, our organization will connect awareness with a practical review of the information, nutrition support, specialty navigation, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
Gastroparesis Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Camilleri M. Gastroparesis: A Review. JAMA. 2026;336(7):587-602. https://doi.org/10.1001/jama.2026.12181
- 2.Sadda VR, Verma R, Aly AE, Zheng P, Ayazi S. Glycemic Control and Diabetes Outcomes After Surgical Therapy for Diabetic Gastroparesis. JAMA Surgery. 2026;161(7):719-726. https://doi.org/10.1001/jamasurg.2026.1593
- 3.Olubodun T, Osundina MA, Soyoye DO, de Oliveira NMB, Olubodun AB, Ogundele OO. Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes. PLOS ONE. 2026;21(8):e0354497. https://doi.org/10.1371/journal.pone.0354497
- 4.Fagan GP, Rabheru R, Bear DE, Lomer MCE. A Scoping Review of Dietary Management for Nondiabetic Gastroparesis: Evidence Limitations and Research Gaps. Journal of the Academy of Nutrition and Dietetics. 2026;126(8). https://doi.org/10.1016/j.jand.2026.156302
- 5.Sonaiya S, Dahiya DS, Tun KM, Mange P, Inamdar S, Chandan S, et al. Gastric Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection for the Treatment of Refractory Gastroparesis: A Cost-Effectiveness Analysis. Journal of Clinical Gastroenterology. 2026;60(6):514-522. https://doi.org/10.1097/mcg.0000000000002368
- 6.Abokresha MM, Tousb MAW, Elden MEE, Diab WA, Taha BO. Prevalence and clinical determinants of diabetic gastroparesis in type 2 diabetes: a symptom- and scintigraphy-based cross-sectional study. BMC Gastroenterology. 2026;26(1). https://doi.org/10.1186/s12876-026-04979-z
- 7.Wang Z, Ma M, Wu X, Xu X, Xu X, Cui B, et al. Development and validation of a rapid 15-minute gastric ultrasound protocol for suspected gastroparesis: a prospective diagnostic accuracy study. Annals of Medicine. 2026;58(1):2718626. https://doi.org/10.1080/07853890.2026.2718626
- 8.Draper G, Knowles S. Exploring Brain Fog, Fatigue, Psychological Distress and the Impact on Quality of Life for Those Living with Gastroparesis. Journal of Gastrointestinal and Liver Diseases. 2026;35(1):31-37. https://doi.org/10.15403/jgld-6583
- 9.Parkman HP, Wilson LA, Hasler WL, Grover M, Chumpitazi BP, Burton-Murray H, et al. Predominant Symptom in Gastroparesis: Relationships to Quality of Life, Treatments, and Outcome. Neurogastroenterology and Motility. 2026;38(3):e70287. https://doi.org/10.1111/nmo.70287
- 10.Abraham R, Foong D, Ho V. Combined Gastric Alimetry and Gastric Emptying Scintigraphy Testing Increases Clinician Certainty in the Diagnosis and Management of Suspected Gastroparesis. Journal of Neurogastroenterology and Motility. 2026;32(1):61-70. https://doi.org/10.5056/jnm25094
- 11.Lawlor K, King S. Should gastric emptying scintigraphy studies be performed, as standard, on paediatric patients with suspected gastroparesis? A systematic literature review. Nuclear Medicine Communications. 2026;47(1):11-19. https://doi.org/10.1097/mnm.0000000000002068
- 12.Kilani Y, Gonzalez Mosquera DA, Puelo PC, Aldiabat M, Ruffle JK, Madi MY, et al. The Impact of Cannabis Use in Gastroparesis: A Propensity-Matched Analysis of 41,374 Gastroparesis Patients. The American Journal of Gastroenterology. 2026;121(1):248-257. https://doi.org/10.14309/ajg.0000000000003479
- 13.Parkman HP, Xin Y, Wilson LA, Burton-Murray H, McCallum RW, Sarosiek I, et al. Characterization of Patients With Symptoms of Gastroparesis Having Frequent Emergency Department Visits and Hospitalizations. Clinical Gastroenterology and Hepatology. 2025. https://doi.org/10.1016/j.cgh.2025.01.033
- 14.Soare I, Tudose NA, Stefan CS, Mirică RE. The impact of social determinants of health on diabetic gastroparesis: a retrospective analysis. Frontiers in Public Health. 2025;13:1695472. https://doi.org/10.3389/fpubh.2025.1695472
- 15.Dilmaghani S, Zheng T, Camilleri M. Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review. Clinical Gastroenterology and Hepatology. 2023;21(9):2239-2251. https://doi.org/10.1016/j.cgh.2022.07.011
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Prevalence, causes and diagnostic standard for gastroparesis | [1] | 2026 | Current evidence | Narrative review; prevalence drawn from a 2018 U.S. claims study. |
| Underrecognized delayed gastric emptying in type 2 diabetes | [6] | 2026 | Current evidence | Single tertiary outpatient clinic; 130 participants; cross-sectional design. |
| Gastroparesis associated with glucagon-like peptide-1 receptor agonists | [3] | 2026 | Current evidence | Twelve case reports describing 13 patients; no denominator for incidence. |
| Epidemiology, case identification and rising acute care use | [15] | 2023 | Current evidence | Thirteen studies with data from 1994 to 2019; most relied on diagnosis codes. |
| Predominant symptoms and symptom improvement over follow-up | [9] | 2026 | Continuum of care | Multicenter registry patients; improvement threshold of one point on a symptom index. |
| Surgical therapy and later acute care use in diabetic gastroparesis | [2] | 2026 | Continuum of care | Retrospective electronic record cohort; propensity matching cannot remove all confounding. |
| Access to pediatric gastric emptying testing and alternatives | [11] | 2026 | Access | Thirteen papers; review of test options rather than access data. |
| Bedside gastric ultrasound as a triage step | [7] | 2026 | Access | Single prospective study of 113 participants; needs external validation. |
| Specialist test review and diagnostic certainty | [10] | 2026 | Human infrastructure | Pilot study of 16 patients at one tertiary center. |
| Evidence gaps in dietary management of nondiabetic gastroparesis | [4] | 2026 | Access | Thirteen heterogeneous studies; only two randomized trials with 16 participants. |
| Race, income and acute care use | [13] | 2025 | Equity and trust | Single cohort with questionnaire-reported prior-year utilization. |
| Social determinants and utilization in diabetic gastroparesis | [14] | 2025 | Equity and trust | Retrospective subgroup of 50 patients. |
| Cannabis use and healthcare utilization | [12] | 2026 | Equity and trust | Observational matched cohort; cannabis exposure from records. |
| Brain fog, fatigue and quality of life | [8] | 2026 | Human infrastructure | Online cross-sectional survey of 114 participants; self-reported diagnosis. |
| Cost-effectiveness of refractory gastroparesis procedures | [5] | 2026 | Public communication | Decision model from a U.S. health system perspective over 3 and 12 months. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

